Background Our understanding of coronavirus disease 2019 (COVID-19) and its
implications for patients with inflammatory bowel diseases (IBD) is rapidly evolving. We …

Background Great efforts by the scientific community are rapidly expanding the evidence on
the clinical interplay between Covid-19 and inflammatory bowel disease (IBD). Aims We …

Background & Aims Data on the clinical characteristics of patients with inflammatory bowel
diseases (IBDs) with coronavirus disease 2019 (COVID-19) are scarce. The aim of our …

Background and Aims. The impact of COVID‐19 has been of great concern in patients with
inflammatory bowel disease (IBD) worldwide, including an increased risk of severe …

Background We aimed to characterize patients with inflammatory bowel disease (IBD) and
novel coronavirus disease 2019 (COVID-19). Methods We performed a case series of …

Abstract Background and Aims The COVID-19 risk and disease course in inflammatory
bowel disease [IBD] patients remains uncertain. Therefore, we aimed to assess the clinical …

Abstract Background and Aims As no population-based study has investigated the
susceptibility and disease course of COVID-19 among patients with inflammatory bowel …

Our knowledge of COVID-19 is changing and evolving rapidly, with novel insights and
recommendations, almost on a daily basis. It behooves the medical community to provide …

During the coronavirus disease 2019 (COVID-19) pandemic, many unpredictable changes
have occurred in the medical field. Risk of COVID-19 does not seem to increase in patients …

Background Accurate estimates for the risk of COVID‐19 in IBD, and an understanding of the
impact of COVID‐19 on IBD course and the risk of incident post‐infectious IBD are needed …